Danuglipron
PF-06882961
An orally administered non-peptide GLP-1 receptor agonist studied in randomized trials for type 2 diabetes and weight management. Not FDA approved.
Tracking and educational reference only, on values you enter or import yourself. Not medical advice or a dosing recommendation.
Regulatory status
Not FDA approved
The FDA has not approved this substance for human use. It may be approved elsewhere, studied in the literature, or available through other routes, but it carries no approved US label and therefore no agency-reviewed instructions.
A regulatory status describes paperwork, not safety. An approved compound can still be wrong for a given person, and an unapproved one is neither thereby dangerous nor thereby fine.
Half-life
Not established in a public source. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Not approved for human use; no public label defines handling.
References
- PubChem compound record
- Nat Med 2021: phase 1 multiple ascending-dose study in type 2 diabetes
- Metabolism 2023: review of oral small-molecule GLP-1 receptor agonists
Read the source
Common questions
Danuglipron, answered plainly.
01What is Danuglipron?+
An orally administered non-peptide GLP-1 receptor agonist studied in randomized trials for type 2 diabetes and weight management. Not FDA approved. It is also referred to as PF-06882961. It is listed here under GLP-1 / Metabolic as educational reference, which is not a recommendation to use it.
02Is Danuglipron FDA approved?+
Not FDA approved. The FDA has not approved this substance for human use. It may be approved elsewhere, studied in the literature, or available through other routes, but it carries no approved US label and therefore no agency-reviewed instructions.
03What is the half-life of Danuglipron?+
Not established in a public source. A half-life is an educational pharmacology figure describing how long the body takes to clear half of a substance. It is not a schedule and does not imply one.
04How is Danuglipron stored and handled?+
Not approved for human use; no public label defines handling. Storage conditions come from a manufacturer's own label where one exists, and a compound with no approved label has no agency-reviewed handling instructions at all.
Related in GLP-1 / Metabolic
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.